# EVLA and Optimal Timing of Sclerotherapy

> **NCT04774939** · NA · NOT_YET_RECRUITING · sponsor: **Turku University Hospital** · enrollment: 350 (estimated)

## Conditions studied

- Venous Reflux

## Interventions

- **PROCEDURE:** Endovenous laser ablation

## Key facts

- **NCT ID:** NCT04774939
- **Lead sponsor:** Turku University Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2021-03-15
- **Primary completion:** 2027-03-15
- **Final completion:** 2030-03-15
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2021-03-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04774939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04774939, "EVLA and Optimal Timing of Sclerotherapy". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT04774939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*